** Shares of nutritional product provider S66.AX rise as
much as 1.7% to A$0.3 – biggest intraday pct gain since Jan. 14
** Stock hits its highest level since Jan 21
** Co says its group revenue for Q2 FY21 up by 6% to A$7.5
mln ($5.73 mln) from same period last year urn:newsml:reuters.com:*:nASN000RZ4
** Star Combo Pharma says its Q2 FY21 records positive cash
flow from operating activities of A$500,000, an improvement from
negative cash flow of A$100,000 in Q1 FY21
** As of last close, S66 down 10.6% this year
($1 = 1.3082 Australian dollars)
(Reporting by Aditya Munjuluru in Bengaluru)
((aditya.srivastsav@thomsonreuters.com))